What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Surgery
Keith M. Sullivan mainly investigates Transplantation, Surgery, Internal medicine, Gastroenterology and Bone marrow.
The study incorporates disciplines such as Aplastic anemia, Sickle cell anemia, Disease and Immunology in addition to Transplantation.
His Surgery study frequently draws connections to other fields, such as Anemia.
His is doing research in Leukemia, Hematopoietic stem cell transplantation, Graft-versus-host disease, Immunosuppression and Cumulative incidence, both of which are found in Internal medicine.
The various areas that Keith M. Sullivan examines in his Gastroenterology study include Preparative Regimen, Adverse effect, Azathioprine and Acute lymphocytic leukemia.
His research integrates issues of Lymphoproliferative disorders, Lymphoma, Incidence, Urology and Pulmonary function testing in his study of Bone marrow.
His most cited work include:
- Chronic graft-versus-host syndrome in man: A long-term clinicopathologic study of 20 seattle patients (2129 citations)
- Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia (1233 citations)
- Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation. (998 citations)
What are the main themes of his work throughout his whole career to date?
Internal medicine, Transplantation, Surgery, Gastroenterology and Immunology are his primary areas of study.
His Internal medicine study frequently draws connections between adjacent fields such as Oncology.
Keith M. Sullivan combines subjects such as Aplastic anemia, Bone marrow and Total body irradiation with his study of Transplantation.
His Surgery research is multidisciplinary, relying on both Immunosuppression and Incidence.
His study in Gastroenterology is interdisciplinary in nature, drawing from both Methotrexate, Randomized controlled trial, Cumulative incidence, Methylprednisolone and Fludarabine.
His studies deal with areas such as Scleroderma and Toxicity as well as Cyclophosphamide.
He most often published in these fields:
- Internal medicine (52.60%)
- Transplantation (47.20%)
- Surgery (40.20%)
What were the highlights of his more recent work (between 2011-2021)?
- Internal medicine (52.60%)
- Transplantation (47.20%)
- Hematopoietic stem cell transplantation (15.00%)
In recent papers he was focusing on the following fields of study:
Keith M. Sullivan focuses on Internal medicine, Transplantation, Hematopoietic stem cell transplantation, Oncology and Surgery.
Keith M. Sullivan interconnects Gastroenterology and Placebo in the investigation of issues within Internal medicine.
Keith M. Sullivan studies Graft-versus-host disease, a branch of Transplantation.
His research in Hematopoietic stem cell transplantation intersects with topics in Incidence, Retrospective cohort study, Immunology, Clinical endpoint and Salvage therapy.
His Oncology study incorporates themes from Hematopoietic Stem Cell Mobilization, Granulocyte colony-stimulating factor, Quality of life, Marrow transplantation and Hematopoietic stem cell.
His Cyclophosphamide research incorporates elements of Immunosuppression, Randomized controlled trial and Scleroderma.
Between 2011 and 2021, his most popular works were:
- Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma. (199 citations)
- Umbilical cord blood expansion with nicotinamide provides long-term multilineage engraftment (170 citations)
- A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients. (117 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Disease
The scientist’s investigation covers issues in Internal medicine, Transplantation, Hematopoietic stem cell transplantation, Immunology and Autologous stem-cell transplantation.
His Internal medicine research is multidisciplinary, incorporating elements of Placebo, Surgery and Oncology.
His research in Surgery tackles topics such as Gastroenterology which are related to areas like Pathology.
His studies in Transplantation integrate themes in fields like Umbilical cord, Transplantation Conditioning, Haematopoiesis and Herpes Zoster Vaccine.
His work on Histocompatibility Testing as part of general Immunology study is frequently linked to Surgical mask, therefore connecting diverse disciplines of science.
The Autologous stem-cell transplantation study combines topics in areas such as Adverse effect and Cyclophosphamide.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
